<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Why Moderna (MRNA) Stock Is Trading Up Today — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Why Moderna (MRNA) Stock Is Trading Up Today</h2>
    <div class="badge">2025-09-16T15:40:49+00:00</div>
    <ul>
      <li>After the initial pop the shares cooled down to $24.74, up 3.6% from previous close.</li>
<li>Moderna is down 41.1% since the beginning of the year, and at $24.74 per share, it is trading 65.6% below its 52-week high of $71.99 from September 2024.</li>
<li>Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, Spikevax®.</li>
<li>Moderna’s shares are extremely volatile and have had 50 moves greater than 5% over the last year.</li>
<li>Further bolstering investor confidence, UBS reiterated its &#x27;Buy&#x27; rating and a $70 price target on the stock.</li>
<li>Investors who bought $1,000 worth of Moderna’s shares 5 years ago would now be looking at an investment worth $359.38.</li>
<li>The previous big move we wrote about was 4 days ago when the stock dropped 7.8% as reports revealed Trump administration health officials plan to link COVID-19 vaccines to the deaths of around two dozen children.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Why%20Moderna%20%28MRNA%29%20Stock%20Is%20Trading%20Up%20Today%0A%E2%80%A2%20After%20the%20initial%20pop%20the%20shares%20cooled%20down%20to%20%2424.74%2C%20up%203.6%25%20from%20previous%20close.%0A%E2%80%A2%20Moderna%20is%20down%2041.1%25%20since%20the%20beginning%20of%20the%20year%2C%20and%20at%20%2424.74%20per%20share%2C%20it%20is%20trading%2065.6%25%20below%20its%2052-week%20high%20of%20%2471.99%20from%20September%202024.%0A%E2%80%A2%20Shares%20of%20biotechnology%20company%20Moderna%20%28NASDAQ%3AMRNA%29%20jumped%204%25%20in%20the%20morning%20session%20after%20the%20company%20announced%20positive%20preliminary%20data%20for%20its%20updated%202025-2026%20COVID-19%20vaccine%2C%20Spikevax%C2%AE.%0A%E2%80%A2%20Moderna%E2%80%99s%20shares%20are%20extremely%20volatile%20and%20have%20had%2050%20moves%20greater%20than%205%25%20over%20the%20last%20year.%0A%E2%80%A2%20Further%20bolstering%20investor%20confidence%2C%20UBS%20reiterated%20its%20%27Buy%27%20rating%20and%20a%20%2470%20price%20target%20on%20the%20stock.%0A%E2%80%A2%20Investors%20who%20bought%20%241%2C000%20worth%20of%20Moderna%E2%80%99s%20shares%205%20years%20ago%20would%20now%20be%20looking%20at%20an%20investment%20worth%20%24359.38.%0A%E2%80%A2%20The%20previous%20big%20move%20we%20wrote%20about%20was%204%20days%20ago%20when%20the%20stock%20dropped%207.8%25%20as%20reports%20revealed%20Trump%20administration%20health%20officials%20plan%20to%20link%20COVID-19%20vaccines%20to%20the%20deaths%20of%20around%20two%20dozen%20children.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fwhy-moderna-mrna-stock-is-trading-up-today%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/why-moderna-mrna-stock-trading-154049148.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>